scholarly journals HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab

The Breast ◽  
2020 ◽  
Vol 54 ◽  
pp. 235-241 ◽  
Author(s):  
Shuai Li ◽  
Jiayi Wu ◽  
Ou Huang ◽  
Jianrong He ◽  
Li Zhu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
High Risk ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Estrogen Receptor Positive ◽  
Her2 Positivity

Regarding “Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients”

2011 ◽  
Vol 131 (1) ◽  
pp. 351-352 ◽  
Author(s):  
Hiu-Fung Yuen ◽  
Shu-Dong Zhang ◽  
Ashley San-Yu Wong ◽  
Cian M. McCrudden ◽  
Yu-Han Huang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Estrogen Receptor Positive

Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients

2011 ◽  
Vol 133 (1) ◽  
pp. 49-59 ◽  
Author(s):  
Johanna G. H. van Nes ◽  
Esther M. de Kruijf ◽  
Hein Putter ◽  
Dana Faratian ◽  
Alison Munro ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Estrogen Receptor Positive
Sign in / Sign up

Export Citation Format

Share Document